Caligan Partners LP 13D and 13G filings for Anika Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-30 4:31 pm Purchase | 2024-05-28 | 13D | Anika Therapeutics, Inc. ANIK | Caligan Partners LP | 1,435,993 9.700% | 12,500 (+0.88%) | Filing |
| 2024-03-06 7:30 pm Purchase | 2024-03-04 | 13D | Anika Therapeutics, Inc. ANIK | Caligan Partners LP | 1,423,493 9.700% | 342,133 (+31.64%) | Filing |
| 2023-09-11 06:01 am Purchase | 2023-09-08 | 13D | Anika Therapeutics, Inc. ANIK | Caligan Partners LP | 1,081,360 7.400% | 179,274 (+19.87%) | Filing |
| 2023-08-17 08:00 am Purchase | 2023-08-09 | 13D | Anika Therapeutics, Inc. ANIK | Caligan Partners LP | 902,086 6.200% | 902,086 (New Position) | Filing |